SFM
OMED

Sphera Funds Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Sphera Funds Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-97,100
Closed -$1.84M – 167
2014
Q3 		$1.84M Buy
97,100
+22,100
+29% +$444K 0.23% 97
2014
Q2 		$1.75M Buy
+75,000
New +$1.85M 0.43% 56

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sphera Funds Management's OMED Position: Q4 2014 in Review

Sphera Funds Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2014, closing a stake of 97,100 shares — an estimated $1.84M sold.

Sphera Funds Management first reported a position in OMED in Q2 2014 and held it in 2 quarters. The position peaked at $1.84M in Q3 2014. 68 funds tracked by Wall St. Rank hold OMED as of Q4 2014.

  • Sphera Funds Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Sphera Funds Management sold 97,100 OncoMed Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.84M.
  • Sphera Funds Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • Sphera Funds Management's OncoMed Pharmaceuticals, Inc. position peaked at $1.84M in Q3 2014.
  • 68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2014.

Based on Sphera Funds Management's 13F filing for Q4 2014, filed 12 Feb 2015.